Network Pharmacology and In Vivo Validation Reveal Berberine-Mediated Regulation of the Liver–Brain Inflammatory Axis in MCD-Induced Steatohepatitis
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive immunometabolic liver disorder involving lipid dysregulation, inflammation, fibrosis, and extrahepatic immune–neural responses, yet therapies capable of modulating these interconnected processes remain limited. Berberine (BBR), an isoquinoline alk...